Viewing Study NCT01609803


Ignite Creation Date: 2025-12-24 @ 7:17 PM
Ignite Modification Date: 2025-12-30 @ 2:56 PM
Study NCT ID: NCT01609803
Status: COMPLETED
Last Update Posted: 2016-05-18
First Post: 2012-05-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma
Sponsor: Children's Oncology Group
Organization:

Study Overview

Official Title: Tissue Microarray Studies of the 12q13-q14 Amplicon in Alveolar Rhabdomyosarcoma
Status: COMPLETED
Status Verified Date: 2016-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This research trial studies protein expression in tissue samples from younger patients with rhabdomyosarcoma. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors find better ways to treat cancer.
Detailed Description: PRIMARY OBJECTIVES:

I. To investigate (in two stages) which proteins are overexpressed in association with 12q13-q14 amplification by applying fluorescence in situ hybridization (FISH) and immunohistochemical (IHC) assays to a panel of alveolar rhabdomyosarcomas (ARMS) cases organized into tissue microarrays.

OUTLINE:

Formalin-fixed paraffin-embedded tissue samples are analyzed for 12q13-q14 frequency and protein overexpression by FISH and IHC.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
NCI-2012-01972 REGISTRY CTRP (Clinical Trial Reporting Program) View
COG-ARST12B7 OTHER Children's Oncology Group View